Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma

NCT02446236

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Active, Not Recruiting

Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

NCT02287311

Conditions: Carcinoma, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, +25 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

NCT03463460

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Indiana University Indianapolis, Indiana, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

NCT03534323

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: University of Miami- Sylvester Comprehensive Cancer Center Miami, Florida, United States

Northern Light Eastern Maine Medical Center Brewer, Maine, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Boston Medical Center Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

NCT02503423

Conditions: Carcinoma, Carcinoma, Squamous Cell, Female Urogenital Diseases, +23 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

HonorHealth Research Institute Scottsdale, Arizona, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

View all 68 locations

View Trial Details

Active, Not Recruiting

NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

NCT05359211

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +17 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

NCT05025800

Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, +31 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL

NCT04881838

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Shanghai Children's Medical Center Shanghai, China

View Trial Details

Active, Not Recruiting

BNHL-2015 for Children or Adolescents in China

NCT02405676

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: West China Second University Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Active, Not Recruiting

FT819 in Subjects With B-cell Malignancies

NCT04629729

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +20 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Arizona Phoenix, Arizona, United States

UC Davis Davis, California, United States

Scripps Green Hospital La Jolla, California, United States

View all 18 locations

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions